Dataset Information

S-allylmercaptocysteine Improves NAFLD by Enhancing AhR/Nrf2-mediated Drug Metabolising Enzymes and Reducing NF-κB/IκBα and NLRP3/6-mediated Inflammation

ABSTRACT: S-allylmercaptocysteine Improves NAFLD by Enhancing AhR/Nrf2-mediated Drug Metabolising Enzymes and Reducing NF-κB/IκBα and NLRP3/6-mediated Inflammation

PROVIDER: PRJNA633839 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	SRR11811821_1.fastq.gz	Fastqsanger.gz
	SRR11811821_2.fastq.gz	Fastqsanger.gz
	SRR11811822_1.fastq.gz	Fastqsanger.gz
	SRR11811822_2.fastq.gz	Fastqsanger.gz
	SRR11811823_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Dataset Information

S-allylmercaptocysteine Improves NAFLD by Enhancing AhR/Nrf2-mediated Drug Metabolising Enzymes and Reducing NF-κB/IκBα and NLRP3/6-mediated Inflammation

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets